共 210 条
[1]
Allard WJ(2004)Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases Clin Cancer Res 10 6897-6904
[2]
Matera J(2010)Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial Lancet 376 687-697
[3]
Miller MC(2010)Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study J Clin Oncol 28 4697-4705
[4]
Repollet M(2010)HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial Breast Cancer Res Treat 124 403-412
[5]
Connelly MC(2011)HER2-positive circulating tumor cells in breast cancer PLoS One 6 e15624-1214
[6]
Rao C(2006)HER2 (ErbB2) receptors, a potential therapeutic target in squamous cell carcinoma of oesophagus Br J Cancer 94 1213-9398
[7]
Tibbe AG(2004)HER-2 gene amplification can be acquired as breast cancer progresses Proc Natl Acad Sci USA 101 9393-802
[8]
Uhr JW(2003)HER 2/neu expression and gene amplification in colon cancer Int J Cancer 105 796-13
[9]
Terstappen LW(2010)Circulating tumor cells in colorectal cancer: past, present, and future challenges Curr Treat Options Oncol 11 1-530
[10]
Bang YJ(2009)Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patients Breast Cancer Res Treat 118 523-2645